论文部分内容阅读
目的:观察米非司酮联合利凡诺用于中孕引产的临床疗效。方法:资料随机选自2011年5月-2013年12月我院中孕引产患者118例,按治疗方法随机平分为研究组和对照组,对照组予以利凡诺羊膜腔内注射引产,研究组在对照组基础上口服米非司酮,观察对比两组患者引产后临床疗效。结果:研究组胎盘的胎膜残量及产后的出血量情况明显优于对照组,差异对比有统计学意义(P<0.05);研究组宫缩发动与总产程时间明显低于对照组,差异对比有统计学意义(P<0.05)。结论:米非司酮联合利凡诺用于中孕引产可缩短孕者产程,减少孕者产后出血量。
Objective: To observe the clinical efficacy of mifepristone and rivanol for induction of labor during pregnancy. Methods: The data were randomly selected from May 2011 to December 2013 in our hospital induced abortion in 118 cases of patients, according to the treatment method were equally divided into study group and control group, the control group was levofloxacin intra-articular injection of labor, the study group Oral mifepristone on the basis of the control group, observed and compared the clinical efficacy of induction of labor in two groups of patients. Results: The placenta residual volume and postpartum hemorrhage volume in the study group were significantly better than those in the control group (P <0.05). The duration of uterine contractions and the duration of labor in the study group were significantly lower than those in the control group The comparison was statistically significant (P <0.05). Conclusion: The combination of mifepristone and rivanol for pregnant women during pregnancy can shorten the birth process and reduce the amount of postpartum hemorrhage among pregnant women.